I. Sora et al., mu opiate receptor gene dose effects on different morphine actions: Evidence for differential in vivo mu receptor reserve, NEUROPSYCH, 25(1), 2001, pp. 41-54
Homozygous transgenic knockout mice without mu -opioid receptors lack morph
ine-induced antinociception, locomotion, tolerance, physical dependence, an
d reward. mu receptors thus appear to play central roles in these morphine
actions. Different levels of mu receptor expression are found in different
humans and in different animal strains. In vitro studies indicate that some
morphine responses persist after inactivation of as many as 90% of the ini
tial mu receptor complement, while others are attenuated after inactivating
many fewer receptors. Varying levels of mu receptor reserve could thus exi
st in different mu -expressing neuronal populations in vivo. Heterozygous m
u receptor knockout mice express half of wild-type mu receptor levels. Test
s of morphine actions in these mice reveal evidence for differing mu recept
or reserves in brain circuits that mediate distinct opiate effects. Heteroz
ygotes display attenuated locomotion, reduced morphine self-administration,
intact tolerance, rightward shifts in morphine lethality dose/effect relat
ionships, and variable effects on place preference compared to wild-type mi
ce. They demonstrate full physical dependence, as measured by naloxone-prec
ipitated abstinence following five days of morphine administration. Neuroad
aptive changes in sites other than mu receptors could be involved in some o
f these results. Nevertheless, these data document substantial influences t
hat individual differences in levels of mu receptor expression could exert
on distinct opiate drug effects. They support the idea that functional mu r
eceptor reserve differs among the diverse neuronal populations that mediate
distinct properties of opiate drugs. [Neuropsychopharmacology 25:41-54, 20
01] (C) 2001 American College of Neuropsychopharmacology. Published by Else
vier Science Inc.